Lansionbio

Lansion Biotechnology Co., Ltd. is a biotechnology company dedicated to the research, development, production, and sales of in vitro diagnostic reagents and instruments. The company's core R&D team comes from well-known scientific research institutions and biopharmaceutical companies both domestically and internationally. It has established a precision medical system integrating multiple methodological platforms, including immunity, molecular, and cytology, based on active microfluidic technology and an intelligent instrument platform for integrated one-stop testing systems.Lansionbio meets international leading technical standards and has obtained CE and ISO13485 quality system certifications. It has built a 7,500-square-meter R&D base, which includes a 2,400-square-meter GMP-standard sterile purification production workshop. Lansionbio consistently adheres to innovation, strives for breakthroughs, and insists on starting R&D from the technological source. It has now successfully constructed an internationally leading active microfluidic technology platform. Based on this, it has developed product lines such as laser-induced fluorescence detection, chemiluminescence, electrochemical detection, and molecular diagnostics.In the future, Lansionbio will continue to focus on diversified products supported by active microfluidic technology as its core, with medical testing workstations and general practitioner health stations as new business entities, to complete the closed-loop layout of precision health services. "Pursuing excellence and sincerely protecting every life and health" is the relentless goal of Lansionbio’s team. Lansionbio will continue to upgrade its active microfluidic products, promoting the popularization of precision testing technologies at the grassroots level, accelerating the implementation of China's tiered medical treatment system in primary hospitals, and expanding its market presence not only in overseas markets but also globally.